KUALA LUMPUR – Sunzen Biotech Bhd will manufacture health and beauty products for Xmegami Sdn Bhd starting this year.
Xmegami is a low-capital internet start-up platform, founded in 2017. It has a multi-level marketing license and over 2,000 members in Malaysia who sell its line of health and beauty products produced through contract manufacturing.
The five-year-old company, which is full of energy, innovation, and forward-thinking ideas, has decided to work with Sunzen as a single manufacturer to produce its product line, possibly to have more control over the quality of the items.
Ecolite Biotech Manufacturing Sdn Bhd, a subsidiary of Sunzen, has formed a 49:51 joint venture with Xmegami. It will manufacture the products through a joint venture company with Xmegami at its healthcare facility in Shah Alam, Selangor.
The factory is currently producing products for Sunzen ranging from digestion to bird’s nest to health tonic to family health, but it is underutilized.
Sunzen will convert the underutilized portion of the factory to produce the Xmegami products, with the first roll-out scheduled for the end of this year. According to Teo Yek Ming, Sunzen’s group managing director, this collaboration transforms Ecolite from a traditional to a modern healthcare company, marking a milestone for the Sunzen Group in the healthcare industry.
Ecolite combines ingredients in modern facilities to create formulas based on traditional recipes in order to popularise nutrition and make it easier for the public to obtain nutrition and maintain their health.
The company offers original equipment manufacturing (OEM) and original design manufacturing (ODM), both in accordance with GMP, HACCP, MeSTI, VHM, and JAKIM Halal certification standards.
Teo said that as people’s quality of life improves, they become more health-conscious and interested in health care products, which leads Sunzen to want to partner with Xmegami.
He said in a statement that the collaboration of Ecolite and Xmegami can complete Sunzen’s ecology in the human health care industry while also significantly contributing to the group’s overall business.
The director of Xmegami, Cheong Sheue Xin, hopes that this joint venture will bring more effective and complementary health products to the market. She said that product formulation and quality development will be prioritized at the new Xmegami factory in Kota Kemuning.
Thousands of partners with primary jobs and stay-at-home moms have earned money on the Xmegami platform, particularly during the pandemic, while increasing their value, earning extra money, and improving their quality of life.
During the pandemic, Xmegami posted revenue of RM40 million in 2020, which increased to RM44 million the following year, according to Cheong.